These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12700580)

  • 1. The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities.
    De Boer RA; Pinto YM; Van Veldhuisen DJ
    Microcirculation; 2003 Apr; 10(2):113-26. PubMed ID: 12700580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension and heart failure: a dysfunction of systole, diastole or both?
    Yip GW; Fung JW; Tan YT; Sanderson JE
    J Hum Hypertens; 2009 May; 23(5):295-306. PubMed ID: 19037230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvascular involvement in cardiac pathology.
    Gavin JB; Maxwell L; Edgar SG
    J Mol Cell Cardiol; 1998 Dec; 30(12):2531-40. PubMed ID: 9990524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
    Saccà L; Napoli R; Cittadini A
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor.
    Yoon YS; Uchida S; Masuo O; Cejna M; Park JS; Gwon HC; Kirchmair R; Bahlman F; Walter D; Curry C; Hanley A; Isner JM; Losordo DW
    Circulation; 2005 Apr; 111(16):2073-85. PubMed ID: 15851615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New pathogenetic mechanisms of idiopathic dilated cardiomyopathy: changes in coronary microcirculation].
    Neglia D
    Recenti Prog Med; 2003 Jun; 94(6):247-52. PubMed ID: 12793095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NADPH oxidase and heart failure.
    Murdoch CE; Grieve DJ; Cave AC; Looi YH; Shah AM
    Curr Opin Pharmacol; 2006 Apr; 6(2):148-53. PubMed ID: 16483850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3-mediated activation of myocardial capillary growth.
    Hilfiker-Kleiner D; Limbourg A; Drexler H
    Trends Cardiovasc Med; 2005 May; 15(4):152-7. PubMed ID: 16099380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurohormones and heart failure: the importance of aldosterone.
    Odedra K; Ferro A
    Int J Clin Pract; 2006 Jul; 60(7):835-46. PubMed ID: 16846401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular oxygen sensing need in CNS function: physiological and pathological implications.
    Acker T; Acker H
    J Exp Biol; 2004 Aug; 207(Pt 18):3171-88. PubMed ID: 15299039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
    Gradman AH; Alfayoumi F
    Prog Cardiovasc Dis; 2006; 48(5):326-41. PubMed ID: 16627048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of heart failure following myocardial infarction.
    Struthers AD
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii14-6; discussion ii31, ii43-8. PubMed ID: 15831601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of a high-cholesterol diet on ischemic cardiac dysfunction and remodeling induced by coronary stenosis and coronary occlusion.
    Yaoita H; Yoshinari K; Maehara K; Sando M; Watanabe K; Maruyama Y
    J Am Coll Cardiol; 2005 Jun; 45(12):2078-87. PubMed ID: 15963412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial hypertension and heart failure].
    Mureddu GF; Lomaglio D
    G Ital Nefrol; 2006; 23 Suppl 34():S7-10. PubMed ID: 16633987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial oxidative stress and dysfunction in myocardial remodelling.
    Tsutsui H; Kinugawa S; Matsushima S
    Cardiovasc Res; 2009 Feb; 81(3):449-56. PubMed ID: 18854381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of diabetes on heart rate and other determinants of myocardial oxygen demand in acute coronary syndromes.
    Foo K; Sekhri N; Knight C; Deaner A; Cooper J; Ranjadayalan K; Suliman A; Timmis AD
    Diabet Med; 2004 Sep; 21(9):1025-31. PubMed ID: 15317609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure with preserved ejection fraction: hypertension, diabetes, obesity/sleep apnea, and hypertrophic and infiltrative cardiomyopathy.
    Desai A; Fang JC
    Heart Fail Clin; 2008 Jan; 4(1):87-97. PubMed ID: 18313627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes.
    Brooks BA; Franjic B; Ban CR; Swaraj K; Yue DK; Celermajer DS; Twigg SM
    Diabetes Obes Metab; 2008 Sep; 10(9):739-46. PubMed ID: 17941867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.